Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Lenta's Zoomarkets sales up 2.2 times

12/26/23 LENT

Mitsui withdraws employees from Arctic LNG-2

12/26/23 NVTK

Whoosh has summarized year 2023

12/26/23 WUSH

Mosgorlombard summarized the results of 2023

12/26/23 MGKL

Kazanorgsintez will import substitute polycarbonate for the automotive industry

12/26/23 KZOS

Exploitation of the Sukhoi Log field will start in 2024

12/26/23 PLZL

Lukoil and Nornickel form a large oil and gas cluster

12/26/23 LKOH

Lukoil and Nornickel form a large oil and gas cluster

12/26/23 GMKN

Yandex presented a media service for the Middle East

12/26/23 YNDX

Moscow Exchange to suspend trading in Nornickel shares for split trading

12/25/23 GMKN